The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Allakos, Inc. | Common | 01671P100 | 805,071 | 5,750,506 | SH | OTR | 3,940,261 | 1,810,245 | 0 | ||
Mirum Pharmaceuticals, Inc. | Common | 604749101 | 33,543 | 1,921,118 | SH | SOLE | 1,921,118 | 0 | 0 | ||
Otonomy, Inc. | Common | 68906L105 | 3,247 | 501,899 | SH | SOLE | 501,899 | 0 | 0 | ||
Spruce Bioscience, Inc. | Common | 85209E109 | 52,224 | 2,148,281 | SH | SOLE | 2,148,281 | 0 | 0 | ||
Vapotherm, Inc. | Common | 922107107 | 16,250 | 604,974 | SH | OTR | 0 | 604,974 | 0 |